Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: The in-clinic aspire study

Diabetes Technology and Therapeutics

Volumn 14, Issue 3, 2012, Pages 205-209

  Garg, Satish ^a   Brazg, Ronald L ^b   Bailey, Timothy S ^c   Buckingham, Bruce A ^d   Slover, Robert H ^a   Klonoff, David C ^e   Shin, John ^f   Welsh, John B ^f   Kaufman, Francine R ^f  

^a UNIVERSITY OF COLORADO   (United States)

^b Rainier Clinical Research Center   (United States)

^c AMCR Institute Inc   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e Mills Peninsula Health Services   (United States)

^f MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; AUTOMATION; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; EXERCISE; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SENSOR;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857865549     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0292     Document Type: Article

References (9)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329: 977-986.
2. Brazg RL, Bailey TS, Garg S, Buckingham BA, Slover RH, Klonoff DC, Nguyen X, Shin J, Welsh JB, Lee SW: The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exerciseinduced hypoglycemia. J Diabetes Sci Technol 2011;5:1466-1471.
3. Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR: Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol 2011;5:1137-1141.
4. Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA: Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011;34:2023-2025.
5. Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Bläsig S, Wadien T, Zierow S, Hartmann R, Thomas A: Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther 2011;13:1129-1134.
6. Buckingham B, Wilson DM, Lecher T, Hanas R, Kaiserman K, Cameron F: Duration of nocturnal hypoglycemia before seizures. Diabetes Care 2008;31:2110-2112.
7. Cryer PE: Hypoglycemia begets hypoglycemia in IDDM. Diabetes 1993;42:1691-1693. (Pubitemid 23346403)
8. Cryer PE: Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005;54:3592-3601. (Pubitemid 43334356)
9. Ly TT, Hewitt J, Davey RJ, Lim EM, Davis EA, Jones TW: Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care 2011;34:50-52.